{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-034183","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-07-22T12:30:27+00:00","discovered_at":"2026-07-22T12:35:00.375843+00:00","generated_at":"2026-07-22T12:35:18.510347+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"bioAffinity Technologies partners with Pictor to develop asthma/COPD diagnostics","bullets":["Collaboration integrates bioAffinity's flow cytometry with Pictor's targeted proteomic platform for lung inflammation tests.","Tests aim to match asthma/COPD patients with personalized treatments; asthma/COPD affect 40M Americans and 650M worldwide.","Global asthma/COPD therapeutics market projected to exceed $108B in 2026 and $155B by 2030.","bioAffinity will own IP for tests developed; Pictor retains its platform IP and owns new platform inventions.","Tests initially offered as Laboratory Developed Tests under CLIA; no financial terms disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-034183","json":"https://secwatch.observer/filing/0001493152-26-034183.json","markdown":"https://secwatch.observer/filing/0001493152-26-034183.md","text":"https://secwatch.observer/filing/0001493152-26-034183.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226034183/0001493152-26-034183-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226034183/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-22T12:35:18.510347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}